The Optimal Intervention Time of Bone Marrow Mesenchymal Stem Cells in Ameliorating Cardiac Fibrosis Induced by Viral Myocarditis: A Randomized Controlled Trial in Mice

• Principais autores: Tingting Wu (Autor), Yuan Xie (Autor), Jing Huang (Autor), Ping Li (Autor), Xuliang Wang (Autor), Yaoyao Yan (Autor), Tianhe Xia (Autor), Lei Li (Autor), Feng Zhu (Autor), Hao Li (Autor), Rongzhou Wu (Autor)
• Formato: Livro
• Publicado em: Hindawi Limited, 2017-01-01T00:00:00Z.
• Assuntos: article
• Acesso em linha: Connect to this object online.

Bone marrow-derived mesenchymal stem cells (BMSCs) have recently been introduced to treat cardiovascular diseases, such as myocardial infarction and dilated cardiomyopathy. Nevertheless, there are few researches focused on the application of BMSCs in treating viral myocarditis, not to mention its op...